These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8152811)

  • 1. Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor-beta 1.
    Williams AC; Browne SJ; Manning AM; Daffada P; Collard TJ; Paraskeva C
    Oncogene; 1994 May; 9(5):1479-85. PubMed ID: 8152811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta.
    Manning AM; Williams AC; Game SM; Paraskeva C
    Oncogene; 1991 Aug; 6(8):1471-6. PubMed ID: 1886718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoplastic transformation of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence.
    Williams AC; Harper SJ; Paraskeva C
    Cancer Res; 1990 Aug; 50(15):4724-30. PubMed ID: 2369746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma.
    Williams AC; Browne SJ; Yeudal WA; Paterson IC; Marshall CJ; Lane DP; Paraskeva C
    Oncogene; 1993 Nov; 8(11):3063-72. PubMed ID: 8414507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
    Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
    Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
    Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An acidic environment leads to p53 dependent induction of apoptosis in human adenoma and carcinoma cell lines: implications for clonal selection during colorectal carcinogenesis.
    Williams AC; Collard TJ; Paraskeva C
    Oncogene; 1999 May; 18(21):3199-204. PubMed ID: 10359525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between p53 and TGF beta 1 in control of epithelial cell proliferation.
    Blaydes JP; Schlumberger M; Wynford-Thomas D; Wyllie FS
    Oncogene; 1995 Jan; 10(2):307-17. PubMed ID: 7838530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant p53 tumor suppressor gene causes resistance to transforming growth factor beta 1 in murine keratinocytes.
    Reiss M; Vellucci VF; Zhou ZL
    Cancer Res; 1993 Feb; 53(4):899-904. PubMed ID: 8094035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of TGF-beta activity abrogates growth promoting tumor cell-cell interactions in vivo.
    Theodorescu D; Caltabiano M; Greig R; Rieman D; Kerbel RS
    J Cell Physiol; 1991 Sep; 148(3):380-90. PubMed ID: 1655815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
    Wang H; Lai B; Li J
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
    Okamoto M; Oyasu R
    Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant p53 is not fully dominant over endogenous wild type p53 in a colorectal adenoma cell line as demonstrated by induction of MDM2 protein and retention of a p53 dependent G1 arrest after gamma irradiation.
    Williams AC; Miller JC; Collard TJ; Bracey TS; Cosulich S; Paraskeva C
    Oncogene; 1995 Jul; 11(1):141-9. PubMed ID: 7624121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of radiation-induced G2 delay potentiates cell death by apoptosis and/or the induction of giant cells in colorectal tumor cells with disrupted p53 function.
    Bracey TS; Williams AC; Paraskeva C
    Clin Cancer Res; 1997 Aug; 3(8):1371-81. PubMed ID: 9815821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
    Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line.
    Fink SP; Swinler SE; Lutterbaugh JD; Massagué J; Thiagalingam S; Kinzler KW; Vogelstein B; Willson JK; Markowitz S
    Cancer Res; 2001 Jan; 61(1):256-60. PubMed ID: 11196171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal variation of p53 expression and proliferative phenotype in A253 squamous carcinoma cells.
    Galbraith SC; Foley J; Kats Y; Moy A; Dann P; Burtis WJ; Philbrick WM; Orloff JJ
    Oncol Res; 1996; 8(9):353-61. PubMed ID: 8979269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation.
    Rowland-Goldsmith MA; Maruyama H; Kusama T; Ralli S; Korc M
    Clin Cancer Res; 2001 Sep; 7(9):2931-40. PubMed ID: 11555612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of growth control by TGF-beta occurs at a late stage of mouse skin carcinogenesis and is independent of ras gene activation.
    Haddow S; Fowlis DJ; Parkinson K; Akhurst RJ; Balmain A
    Oncogene; 1991 Aug; 6(8):1465-70. PubMed ID: 1886717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence.
    Chell SD; Witherden IR; Dobson RR; Moorghen M; Herman AA; Qualtrough D; Williams AC; Paraskeva C
    Cancer Res; 2006 Mar; 66(6):3106-13. PubMed ID: 16540660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.